InsidersTradesSigma
Track the Pharmanutra Pharmanutra S.p.a.: First Significant Sales Results in China share price and the full insider trade history of the company, a publicly traded company based in Italy. Shares are quoted on the IT market, under the supervision of Consob. Operating in the Health Care sector, Pharmanutra Pharmanutra S.p.a.: First Significant Sales Results in China has recorded 1 public disclosures. Market capitalisation: €796.7m. The latest transaction was filed on 18 November 2024 (Other). The full history is openly available.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 8,621 of 29,064 companies
61.7
score / 100
Value39
Quality85
FCF yld2.1%
Earn yld2.5%
EV/EBITDA23.8x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 November 2024
关于 Pharmanutra Pharmanutra S.p.a.: First Significant Sales Results in China
Pharmanutra S.p.a. 是一家专注于健康和制药领域的公司。该公司最近公布了其在中国市场的首批显著销售业绩。